Promoting Cooperation to Enhance Teaching with Technology1 by Jepson, Patricia J, Riesen, John W, Chambers, Kim O, Hafs, Harold D

Get full text

Promoting Cooperation to Enhance Teaching with Technology by Jepson, Patricia J., Riesen, John W., Chambers, Kim O., Hafs, Harold D., Schoknecht, Patricia A., Pollak, E. John

Get full text

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates by Jones, Bryan E, Brown-Augsburger, Patricia L, Corbett, Kizzmekia S, Westendorf, Kathryn, Davies, Julian, Cujec, Thomas P, Wiethoff, Christopher M, Blackbourne, Jamie L, Heinz, Beverly A, Foster, Denisa, Higgs, Richard E, Balasubramaniam, Deepa, Wang, Lingshu, Zhang, Yi, Yang, Eun Sung, Bidshahri, Roza, Kraft, Lucas, Hwang, Yuri, Žentelis, Stefanie, Jepson, Kevin R, Goya, Rodrigo, Smith, Maia A, Collins, David W, Hinshaw, Samuel J, Tycho, Sean A, Pellacani, Davide, Xiang, Ping, Muthuraman, Krithika, Sobhanifar, Solmaz, Piper, Marissa H, Triana, Franz J, Hendle, Jorg, Pustilnik, Anna, Adams, Andrew C, Berens, Shawn J, Baric, Ralph S, Martinez, David R, Cross, Robert W, Geisbert, Thomas W, Borisevich, Viktoriya, Abiona, Olubukola, Belli, Hayley M, de Vries, Maren, Mohamed, Adil, Dittmann, Meike, Samanovic, Marie I, Mulligan, Mark J, Goldsmith, Jory A, Hsieh, Ching-Lin, Johnson, Nicole V, Wrapp, Daniel, McLellan, Jason S, Barnhart, Bryan C, Graham, Barney S, Mascola, John R, Hansen, Carl L, Falconer, Ester

Request full text

Insulin resistance and chronic kidney disease progression, cardiovascular events, and death: findings from the chronic renal insufficiency cohort study by Schrauben, Sarah J, Jepson, Christopher, Hsu, Jesse Y, Wilson, F Perry, Zhang, Xiaoming, Lash, James P, Robinson, Bruce M, Townsend, Raymond R, Chen, Jing, Fogelfeld, Leon, Kao, Patricia, Landis, J Richard, Rader, Daniel J, Hamm, L Lee, Anderson, Amanda H, Feldman, Harold I

Get full text

horizon scan for species conservation by zoos and aquariums by Gusset, Markus, Fa, John E, Sutherland, William J

Get full text

LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection by Jones, Bryan E, Brown-Augsburger, Patricia L, Corbett, Kizzmekia S, Westendorf, Kathryn, Davies, Julian, Cujec, Thomas P, Wiethoff, Christopher M, Blackbourne, Jamie L, Heinz, Beverly A, Foster, Denisa, Higgs, Richard E, Balasubramaniam, Deepa, Wang, Lingshu, Bidshahri, Roza, Kraft, Lucas, Hwang, Yuri, Žentelis, Stefanie, Jepson, Kevin R, Goya, Rodrigo, Smith, Maia A, Collins, David W, Hinshaw, Samuel J, Tycho, Sean A, Pellacani, Davide, Xiang, Ping, Muthuraman, Krithika, Sobhanifar, Solmaz, Piper, Marissa H, Triana, Franz J, Hendle, Jorg, Pustilnik, Anna, Adams, Andrew C, Berens, Shawn J, Baric, Ralph S, Martinez, David R, Cross, Robert W, Geisbert, Thomas W, Borisevich, Viktoriya, Abiona, Olubukola, Belli, Hayley M, De Vries, Maren, Mohamed, Adil, Dittmann, Meike, Samanovic, Marie, Mulligan, Mark J, Goldsmith, Jory A, Ching-Lin, Hsieh, Johnson, Nicole V, Wrapp, Daniel, Mclellan, Jason S, Barnhart, Bryan C, Graham, Barney S, Mascola, John R, Hansen, Carl L, Falconer, Ester

Request full text